The purpose of this research study is to evaluate the safety, tolerability and pharmacokinetics MEC/10/03/026 Approve of single doses of AMG 139 in Dr John Wishart Intervention healthy subjects and in subjects with moderate to severe Psoriasis. Invalid MEC/10/04/037 CICL670A2303 Mrs Fay Sommerville Intervention Application An evaluation of the relationship between intestinal Crohn’s MEC/10/06/059 Approve Professor Anita Nolan Kate O'Connor Intervention Disease and Oral Crohn’s Disease. An evaluation of the relationship Invalid MEC/10/06/059 between intestinal Crohn’s Professor Anita Nolan Intervention Application disease and oral Crohn’s disease Prevalence of sleep symptoms MEC/10/068/EXP Approve within high school and university Dr Antonio Fernando Intervention students in New Zealand Have special authority requirements been associated MEC/10/090/EXP Approve with differential access to Dr Suneela Intervention atorvastatin and clopidogrel by socio-demographic status? MEC/10/10/099 Approve ANZ NMO Collaboration Dr Jennifer Pereira Intervention ADHB Research Office - Dr MEC/10/12/130 Approve Professor Edward Gane Intervention Woodnorth,CDHB Research Office ADHB Research Office - Dr TMC435HPC3007 PROMISE – MEC/10/12/131 Approve Professor Ed Gane Intervention Woodnorth,CDHB Research Office
MEC/10/03/026 Approve The purpose of this research study is to evaluate the safety, tolerability and pharmacokinetics of single doses of AMG 139 in healthy subjects and in subjects with moderate to severe Psoriasis. Dr John Wishart Intervention MEC/10/04/037 Invalid Application CICL670A2303 Mrs Fay Sommerville Intervention MEC/10/06/059 Approve An evaluation of the relationship between intestinal Crohn’s Disease and Oral Crohn’s Disease. Professor Anita Nolan Kate O'Connor Intervention MEC/10/06/059 Invalid Application An evaluation of the relationship between intestinal Crohn’s disease and oral Crohn’s disease Professor Anita Nolan Intervention MEC/10/068/EXP Approve Prevalence of sleep symptoms within high school and university students in New Zealand Dr Antonio Fernando Intervention MEC/10/090/EXP Approve Have special authority requirements been associated with differential access to atorvastatin and clopidogrel by socio-demographic status? Dr Suneela Intervention MEC/10/10/099 Approve ANZ NMO Collaboration Dr Jennifer Pereira Intervention MEC/10/12/130 Approve Professor Edward Gane ADHB Research Office - Dr Woodnorth,CDHB Research Office Intervention MEC/10/12/131 Approve TMC435HPC3007 – PROMISE Professor Ed Gane ADHB Research Office - Dr Woodnorth,CDHB Research Office Intervention
northern-a-ethics-committee-annual-report-2013.docx